INTRODUCTION
Metabolic fitness is important for proper T cell function. Upon activation, T cells require increased glucose uptake to meet the energy and biosynthesis demands required for T cell activation, clonal expansion, and effector function . Many observations collectively support the importance of glucose for T cell responses. Culturing T cells in limited glucose inhibits the proliferation, survival, and expression of effector molecules, including interferon-g (IFN-g) (Cham et al., 2008; Cham and Gajewski, 2005; MacIver et al., 2013) . Similarly, surface expression of the glucose transporter Glut-1 is critical during activation to sustain T cell effector function (Jacobs et al., 2008) . Glycolysis promotes IFN-g expression both through epigenetic and post-transcriptional mechanisms Peng et al., 2016) , whereas glycolysis inhibition leads to increased expression of immune-regulatory receptors, such as programmed cell death protein-1 (PD-1), which can drive T cell exhaustion (Bengsch et al., 2016; Patsoukis et al., 2015) .
Further in vivo models support the importance of glucose availability to sustain T cell function. T cells isolated from fasting animals exhibit long-lasting metabolic and functional defects marked by decreased glucose uptake (Saucillo et al., 2014) . Also, T cells in the tumor microenvironment must compete with tumor cells for available glucose, which limits T cell activity and favors tumor progression Ho et al., 2015) . Effector T cells and tumor cells share many metabolic features, such as engaging Warburg metabolism (aerobic glycolysis) or exhibiting increased dependence on glutamine to support biosynthesis needs. Tumor cells and immune cells also compete for other nutrients, such as the amino acids tryptophan and arginine (Renner et al., 2017) .
It is well recognized that the short-chain fatty acid acetate is an important alternative carbon source for cancer cells to support survival and proliferation under low-glucose conditions (Bulusu et al., 2017; Comerford et al., 2014; Lyssiotis and Cantley, 2014; Schug et al., 2015) . Acetate also has a major effect on immune cell function. For example, a systemic increase in acetate induced by infection is required for optimal memory CD8 + T cell function via a mechanism involving increased GAPDH acetylation and enhanced glycolysis (Balmer et al., 2016) . Furthermore, addition of acetate in vitro has been shown to enhance IFN-g gene transcription (Peng et al., 2016) . Further stressing the role of acetate in enhancing the immune response, synthesis of acetate from ethanol is critical for enhancing the inflammatory response in macrophages through increased histone acetylation at promoter regions of pro-inflammatory genes in acute alcoholic hepatitis (Kendrick et al., 2010) . Given the potential competition between tumor cells and effector T cells to access glucose, we set out to explore whether acetate could correct cytokine production in glucose-restricted T cells and, ultimately, T cells in the tumor microenvironment.
RESULTS

Acetate Restores IFN-g Production in T Cells under Chronic Glucose Restriction
To understand how T cells metabolically adapt to nutrientrestrictive environments, we established an in vitro model in which naive OT-I T cells were activated with ovalbumin (OVA) peptide in medium containing 25 mM glucose and then cultured in medium containing 1 mM glucose for 1 or 5 days, followed by overnight culture supplemented with or without 5 mM acetate ( Figure 1A ). To examine how acetate affects T cell responsiveness in low glucose, we measured intracellular IFN-g after phorbol 12-myristate 13-acetate (PMA)-ionomycin restimulation. As expected, T cells cultured in 1 mM glucose produced significantly less IFN-g compared with T cells cultured in 25 mM glucose (Figures S1A and S1B). However, IFN-g expression was markedly increased in cells that had been supplemented with 5 mM acetate compared with those in 1 mM glucose alone ( Figures 1B and 1C ). These effects were accompanied by an associated increase in Ifng mRNA after acetate treatment (Figure 1D ). Acetate also significantly boosted IFN-g secretion by cells from the day 9 time point, suggesting that the effect of acetate intensifies over prolonged glucose restriction ( Figure 1E ). Importantly, supplemental acetate did not affect cell survival ( Figure 1F ), proliferation ( Figure 1G) (G) Analysis of cell proliferation using CellTrace Violet dye. The graph shows the fraction of cells diluting the dye over 24 h of culture under the indicated conditions. Mean ± SEM, n = 2 independent experiments.
(H) Quantification of lactate production as a measure of aerobic glycolysis in the medium of cells cultured for 24 h under the indicated conditions. Mean ± SEM, n = 2 independent experiments.
( Figure 1H ), which was instead decreased in cells cultured in 1 mM glucose compared with cells cultured in 25 mM glucose ( Figure S1C ). These data indicate that, although acetate substituted for glucose in terms of restoring cytokine production, it did not substitute for glucose in other metabolic processes in the cell. Furthermore, supplemental acetate had little effect on CD8 + T cell activation marker expression ( Figure S1D ), cell size ( Figure S1E ), and granzyme B expression ( Figure S1F ). Based on earlier work (Kendrick et al., 2010) , we reasoned that the increased IFN-g mRNA ( Figure 1D ) could reflect the ability of acetate to substitute for glucose-derived citrate in the production of acetyl-CoA, which serves as an acetyl donor for histone acetylation and, therefore, supports gene transcription. Consistent with this idea, we observed enhanced IFN-g protein and Ifng mRNA expression in T cells exposed to valproic acid (VPA), a histone deacetylase inhibitor that augments global histone acetylation (Gö ttlicher et al., 2001) (Figures 1B-1D ). These results illustrate that increased histone acetylation correlates with enhanced T cell effector function, even in T cells exposed to low-glucose conditions (Agarwal et al., 2009; Araki et al., 2008) .
Acetate Is Incorporated into Histones and Enhances Histone Acetylation in Glucose-Restricted T Cells
To determine whether acetate enhances IFN-g production in glucose-deprived T cells by promoting histone acetylation and supporting gene transcription, we first asked whether glucoserestricted T cells are able to competently acquire and utilize exogenous acetate. Acetate enters cells through monocarboxylate transporters (MCTs) or aquaporins (Halestrap and Wilson, 2012; Rae et al., 2012) and, when in the cell, can be converted to acetyl-coenzyme A (CoA) (Watkins et al., 2007) by one of three acetyl-CoA synthetase enzymes (ACSS1-ACSS3). Acetyl-CoA is essential for many biological processes, including protein acetylation and lipogenesis. Because MCT-1 and MCT-4 have been reported to mediate significant transport of acetate in many tissues (Merezhinskaya et al., 2004) , we questioned whether glucoserestricted T cells were competent in importing exogenous acetate. We observed that MCT-1 and MCT-4 proteins were expressed on T cells over a range of glucose concentrations ( Figures S2A and S2B ). Moreover, their expression was stable throughout the duration of the culture, supporting the notion that T cells could acquire acetate when available in the extracellular environment. We also found that ACSS2, the isoform that plays the dominant role in acetate utilization in mammalian cells (Comerford et al., 2014) , was expressed in T cells and was unaffected by glucose concentration ( Figure S2A ).
To assess whether T cells acquired exogenous acetate, we exposed activated T cells to radioactive [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] acetate and measured the incorporation of 14 C into histones and lipids. 14 C was enriched in both histones ( Figure 2A ) and lipids ( Figure S2C ). We next assessed global histone acetylation in glucose-restricted T cells by western blotting. We found that acetylation of the histone proteins H3 and H4 was increased by supplemental acetate ( Figure 2B ). We also observed that T cells under prolonged glucose restriction (day 9) had lower H3K9-14 and H3K27 acetylation compared with cells under acute glucose restriction (day 5), and these acetylation marks were restored by addition of acetate ( Figures 2C and S2D ). Of note, VPA treatment increased histone acetylation at all time points (Figures 2B and 2C) .
We further assessed the effects of supplemental acetate on histone acetylation by performing genome-wide ChIP sequencing analysis of acetylation of H3K27 in T cells cultured in 1 mM glucose with or without supplemental acetate. We found that acetate supplementation modestly increased H3K27 acetylation in an area of 2 kbp around the transcription start sites (TSSs) of genes in clusters 1, 2, and 3, where clusters are defined by their similarity in H3K27 acetylation profile ( Figures 2D and 2E) ; no substantial H3K27 acetylation was detected around the TSSs of genes in cluster 4. This analysis also revealed that there was no marked difference in the pattern of H3K27 acetylation around TSSs but, rather, that acetate supplementation globally enriches the overall level of acetylation ( Figure 2E ). These findings are in keeping with our hypothesis that glucose-restricted T cells are able to acquire and utilize acetate to promote histone acetylation.
Acetate Promotes Chromatin Accessibility in GlucoseRestricted T Cells The increased histone acetylation, a process known to correlate with transcriptional activation (Allfrey et al., 1964; Verdin and Ott, 2015) , evident in glucose-restricted T cells after supplemental acetate prompted us to perform ATAC-seq analysis. We expected these data to reveal whether the enhanced histone acetylation evident after acetate treatment was linked to changes in chromatin accessibility. We compared the chromatin profiles of T cells cultured in 1 mM glucose with or without supplemental acetate from different time points (day 5 and 9). We found that day 5-activated T cells cultured in 1 mM glucose with acetate had increased chromatin accessibility at 41 regions ( Figure 3A ) compared with cells cultured in 1 mM glucose alone. Cells that were cultured for an additional 4 days in 1 mM glucose (day 9) and then treated with acetate showed increased accessibility at 255 regions ( Figure 3B ) compared with cells cultured in 1 mM glucose alone. Together, our data show that acetate promotes histone acetylation and chromatin accessibility in T cells that are under glucose-limiting conditions and that this effect of acetate intensifies the longer the cells are deprived of glucose.
We also performed a pathway analysis of the 263 genes marked by peaks after acetate treatment on day 9 and found that the majority of significant gene ontology terms were related to signaling pathways (Tables S1A and S1B). Of note, one of these genes was Bhlhe40, which is a transcription factor that is critical for T cell function (Lin et al., 2014) and for maintaining active histone marks at the loci of CD8 + T cell effector molecules (Li et al., 2018, J. Immunol., abstract) . Overall, the data suggest that, in the face of glucose restriction, supplemental acetate facilitates chromatin accessibility at genes that promote CD8 + T cell effector function.
Acetate Augments Expression of a Cohort of Restimulation-Associated Genes in Glucose-Restricted T Cells
To assess whether acetate treatment increases effector gene expression in T cells experiencing glucose restriction, we performed RNA sequencing (RNA-seq) analysis on T cells after PMA-ionomycin restimulation. Principal-component analysis revealed that the most significant changes in gene expression correlated to the length of time in culture, whereas, by comparison, acetate supplementation had a limited effect on the transcriptional profiles ( Figure 3C ). Focusing on analysis of different time points, we found that acetate supplementation substantially affected the transcriptional landscape of cells cultured in 1 mM glucose, with 1,109 differentially expressed genes (DEGs) on day 5 and 461 DEGs on day 9, between the conditions (Figure 3D) . A cohort of 151 DEGs was commonly regulated by acetate at both time points ( Figure 3D ). To assess whether acetate had any transcriptional effect on effector T cell function, we performed a gene ontology analysis of the DEGs identified in Figure 3D and concentrated on the top 5 enriched pathways in each group ( Figure 3E ). We identified a cohort of restimula- (D) Genome-wide chromatin immunoprecipitation sequencing (ChIP-seq) analysis of acetylation of H3K27 in T cells treated as described in Figure 1A .
On the y axis, every line represents the acetylation profile of a specific gene. Genes were clustered according to the H3K27 acetylation profile pattern. Reported on the x axis is the distance from the transcription start site (TSS) of every gene. The bars on the side of each graph represent the fold enrichment, following a color scheme (orange, high enrichment; blue, low enrichment). n = 2 biological replicates.
(E) Global representation of the data shown in (D) (day 9) as an enrichment profile. Culture conditions are reported in the color legend. On the y axis, the fold enrichment is shown. Reported on the x axis is the distance from the TSS.
tion-associated genes belonging to immune response-related pathways whose expression was enhanced by acetate. Among those, we found genes encoding for IFN-g, granzymes, tumor necrosis factor (TNF), and the transcription factor T-bet (Tbx21), which controls IFN-g expression (Szabo et al., 2000 ; Figure 3E ). Of note, acetate increased the expression of some of these transcripts, such as Tnf and Tbx21, only at day 9, suggesting that acetate can have additional effects on T cell effector function after prolonged glucose restriction.
Ex Vivo Acetate Treatment Enhances IFN-g Production in Exhausted T Cells
Our in vitro culture model allowed us to tightly control glucose availability. However, we next aimed to obtain more direct in vivo evidence to support our findings. To this end, we isolated tumorinfiltrating lymphocytes (TILs) from B16 melanoma tumors 21 days after subcutaneous implantation in mice ( Figure 4A ) and treated them with or without supplemental acetate ex vivo. Based on earlier work Ho et al., 2015) , we reasoned that, at this later time point, TILs would have experienced prolonged glucose restriction and shown some hyporesponsive phenotypes analogous to T cells cultured in 1 mM glucose. Indeed, as in T cells cultured under glucose restriction (data not shown), PD-1 was highly expressed on the isolated TILs ( Figure 4B ). Moreover, treating TILs for 4 h with supplemental acetate ex vivo significantly increased the fraction of TILs expressing IFN-g after PMA-ionomycin restimulation compared with PBS-treated TILs ( Figures 4C-4E ), indicating that acetate promotes responsiveness in T cells isolated directly from the tumor microenvironment. We also co-transferred OT-I CD8 + T cells and EL4-OVA lymphoma tumor cells into mice and, 6 days later, administered one intraperitoneal injection of acetate (500 mg/kg) ( Figure 4F ). Upon SIINFEKL peptide restimulation, we found that acetate administration significantly increased the frequency of IFN-g-producing donor cells isolated from the peritoneal cavity compared with PBS-injected controls ( Figures 4G-4I ).
To further corroborate our findings, we isolated lymphocytes from the blood of patients chronically infected with hepatitis C virus (HCV). We hypothesized that, in this scenario, T cells may experience a setting that is similar to glucose restriction, whether from a lack of available substrate or a lack of ability to acquire substrate, during their response to persistent virus infection that may potentially lead to T cell exhaustion and/or hyporesponsiveness (Bengsch et al., 2016; Wedemeyer et al., 2002) . We found that acetate treatment increased the expression of effector cytokines such as IFN-g and TNF only in CD8 + T cells expressing high levels of PD-1 compared with PBS-treated counterparts ( Figure 4J and 4K). Of note, acetate also enhanced the expression of XCL-1 while not affecting CCL-3 and interleukin-2 (IL-2) expression ( Figures  S3A-S3C ). Taken together, our data show that exogenous acetate increases histone acetylation, chromatin accessibility, and cytokine production even in cells under prolonged glucose restriction.
The Enhancing Effect of Acetate on IFN-g Production Is Dependent on ACSS Enzymes
We reasoned that acetate was able to restore the function of glucose-restricted T cells by providing cells with an alternative substrate for dynamic histone acetylation required for activation-induced gene expression. This process would require the ACSS-mediated conversion of cytosolic acetate to acetyl-CoA (Bulusu et al., 2017; Mews et al., 2017) . We next tested whether the acetate-dependent rescue of cytokine production was dependent on ACSS2. We used short hairpin RNAs (shRNAs) to selectively silence Acss2 (Acss2 shRNA; Figure 5A ). Suppression of ACSS2 by Acss2 shRNA rendered glucose-restricted T cells less responsive to the acetate-driven increases in IFN-g production ( Figure 5B ), an effect that was accompanied by reduced incorporation of 14 C carbon from radioactively labeled acetate into histones ( Figure 5C ). This did not reflect a histonespecific event because acetate-derived carbon incorporation into fatty acids was also diminished in Acss2 shRNA-treated T cells (Figure 5D ), presumably reflecting diminished overall availability of the acetyl-CoA donor. Together, these data support the view that, in glucose-restricted T cells, cytokine production can be promoted by exogenous acetate through ACSS2-dependent production of acetyl-CoA, which serves as a donor for histone acetylation, promoting activation-induced gene expression.
To validate our approach, we traced heavy labeled 13 C-acetate into tricarboxylic acid (TCA) cycle intermediates using mass spectrometry in T cells transduced with Acss1/2 shRNA and observed decreased 13 C incorporation into fatty acids and TCA cycle intermediates ( Figure 5E ). Enforced expression of Acss2 in T cells increased 13 C-acetate-derived carbon incorporation in citrate and fatty acids ( Figure 5F ). Together, these data indicate that ACSS enzymes mediate the conversion of exogenously supplied acetate to acetyl-CoA, which then feeds into different metabolic pathways.
ACSS2 Expression Contributes to Optimal Effector T Cell Function In Vivo
To circumvent possible confounding issues of adding exogenous acetate to cultured cells, we assessed the role of ACSS2 on IFN-g production by T cells in an in vivo setting. We remained focused on ACCS2 because this isoform was expressed by CD8 + T cells ( Figure S2A ), was shown to be critical for acetate utilization (Comerford et al., 2014) , and because of our Acss2 shRNA data ( Figures 5A-5F ). We subcutaneously injected 1 3 10 6 EL4-OVA lymphoma tumor cells and then intravenously transferred 5 3 10 6 activated OVA-specific OT-I cells transduced with either control or Acss2 shRNA into Thy1.1 + recipient mice 5 days post-tumor transplantation ( Figure 5G ). On day 7, we examined donor OT-I T cells in the peripheral blood and found that Acss2 knockdown significantly reduced the fraction of cells capable of producing IFN-g and negatively affected the amount of IFN-g produced by the cells (Figures 5H-5J ). Consistent with these findings, tumor clearance was impaired in mice that received Acss2 shRNA-transduced OT-I T cells compared with those that received OT-I T cells transduced with the control shRNA ( Figure 5K ). Further analysis revealed that TILs expressing Acss2 shRNA exhibited reduced IFN-g expression compared with TILs expressing control shRNA ( Figures 5G and 5L-5N ). These data suggest that antigen-specific T cell effector functions are supported by ACSS2 under nutrient-limiting conditions such as cancer, presumably by permitting T cells to utilize endogenous acetate.
DISCUSSION
T cells must acquire sufficient nutrients to engage the appropriate metabolism to support effector functions during infection and cancer (Buck et al., , 2017 Buck et al., 2017; Chang et al., 2013; Michalek and Rathmell, 2010; O'Sullivan and Pearce, 2015; . Nutrient competition can remarkably influence the immune response, and nutrient depletion in the tumor microenvironment can lead to T cell hyporesponsiveness and tumor progression Ho et al., 2015; Mellor and Munn, 2008; Mockler et al., 2014) . A recent paper showed that TILs in renal cell carcinoma suffer from glycolytic and mitochondrial insufficiency, which impairs their function , further highlighting the importance of appropriate metabolic remodeling in these cells. As a primary energy resource, glucose plays an essential role in supporting cellular bioenergetics and maintaining normal cell function. When transiting to environments with limited nutrients and oxygen, cancer cells reprogram their metabolism to cope with environmental changes in a manner dependent on alterative substrates, as do immune cells. We found that acetate, a unique metabolite positioned at the intersection of metabolism and epigenetic regulation, enhances IFN-g production from T cells during prolonged glucose restriction. The maintenance of MCT-1, MCT-4, and ACSS2 expression over a range of glucose concentrations indicates that T cells maintain the ability to acquire and utilize acetate in situations when glucose becomes limited. Although acetate was able to restore cytokine production in these cells, and it contributed to histone acetylation, it did not replace the effects of glucose in terms of lactate production and proliferation. Acetate feeds into the cellular pool of acetyl-CoA and takes part in the TCA cycle and in subsequent anabolic pathways, such as fatty acid, cholesterol, and hexosamine biosynthesis (Puleston et al., 2017) . It is possible that acetate does not substitute for glucose in the glycolysis pathway and in those branching from it, such as the pentose phosphate and serine biosynthesis pathways, which are key to sustaining T cell proliferation (Ma et al., 2017) . Our data highlight the role of acetate as an alternative carbon source for histone acetylation in T cells when access to glucose is limited. Although our studies did not investigate ACSS localization, it is possible that the observed enhancement in T cell cytokine production after acetate treatment is the result of differential expression of ACSS2 in the nuclear compartment, which has been shown to directly maintain histone acetylation in cancer cells and neurons (Bulusu et al., 2017; Mews et al., 2017) . In our in vitro culture system, we used 5 mM sodium acetate, which may be considered a non-physiological concentration because acetate levels in healthy human and murine blood range from 50 to 600 mM (Hosios and Vander Heiden, 2014) . However, during infection, serum acetate concentrations in mice have been shown to reach 2-5 mM (Balmer et al., 2016) . Also, chronic alcoholics have blood acetate levels in the range of 1 mM, indicating that blood acetate levels can be much higher depending on the context (Nuutinen et al., 1985) . It is also interesting to consider that acetate levels in local microenvironments and particular niches may be higher than what is measured in the blood. A recent study has revealed that diet-derived short-chain fatty acids (SCFAs), including acetate, boost CD8 + T cell effector function by enhancing cellular metabolism (Trompette et al., 2018) . More work will need to be done to determine the relevance of acetate utilization by T cells in a variety of in vivo settings.
Our data showed that supplemental acetate enhances global acetylation of histones and that 263 genes had enhanced accessibility after acetate treatment (Table S1A) , and within these peaks were genes, such as Bhlhe40, with important roles in T cell function (Lin et al., 2014; Li et al., 2018, J. Immunol., abstract) . Acetate exposure also slightly increased accessibility to the promoter region of T-bet (encoded by the gene Tbx21), which may correlate with the increased T-bet gene expression evident after acetate treatment ( Figure 3E ). Of note, the IFN-g gene was equally accessible in acetate-treated and -untreated cells. This suggested to us that mechanisms in addition to chromatin accessibility, such as transcription factor binding driving gene expression, contribute to differences in IFN-g production upon acetate exposure. Overall, our data imply that, within the genes represented by the open chromatin peaks, there are genes that encode proteins that regulate the expression of the 461 DEGs emerging from the RNA-seq data of day 9 acetatetreated cells. Although not addressed in this study, the relationship between genes in open chromatin and DEGs as well as how these DEGs regulate T cell function are subjects of future investigation.
In summary, we have shown that prolonged glucose restriction contributes to T cell hyporesponsiveness characterized by defects in IFN-g production and that administration of acetate promotes chromatin accessibility, histone acetylation, and cytokine production in glucose-restricted T cells in an ACSS-dependent manner. Recent studies have shown that exhausted T cells have progressively acquired, exhaustion-associated DNA methylation programs and that blocking this epigenetic reprogramming may boost immune checkpoint blockade therapies (Ghoneim et al., 2017) . The SCFA acetate can promote chromatin accessibility, histone acetylation, and IFN-g production in T cells rendered hyporesponsive by glucose restriction. Understanding nutrient competition in the tumor microenvironment and how this affects T cell nutrient acquisition may be an important component in the generation of future therapies to promote durable T cell immunity in cancer. 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice and tumor models OT-I transgenic mice (C57BL/6-Tg(TcraTcrb)1100Mjb/J; Jax, 003831), CD45. For the experiments in Figures 4A-4E , the flanks of CD45.1 + C57BL/6 mice were shaved and the mice were subcutaneously injected with 10 6 B16 melanoma tumor cells in 100 mL PBS. Tumor growth was monitored every 2-3 days by measuring the diameter of the tumor mass. On day 21 after tumor implant, mice were humanely euthanized and the tumor mass harvested and further processed (see below). For the experiments in Figures 4F-4I , 10 7 EL4-OVA lymphoma tumor cells were intraperitoneally injected in 200 mL of PBS in CD45.1 + C57BL/6 mice. Concomitantly, 2x10 4 naive OT-I CD8 + T cells were intravenously injected in the same mice. 6 days after the tumor transfer, mice were treated with either a single bolus of sodium acetate in PBS (500 mg/Kg) or with PBS alone. 1 day later, mice were euthanized and the peritoneal content was harvested for further analysis. For experiments in Figures 5G-5N , the flanks of Thy1.1 + C57BL/6 mice were shaved and the mice were subcutaneously injected with 10 6 EL4-OVA lymphoma tumor cells in 100 mL PBS. 5 days later, mice received 5x10 6 activated OT-I cells transduced with the viruses indicated in the text. On day 7, mice were bled and the cells processed for further analysis. Tumor growth was monitored every 2-3 days by measuring the diameter of the tumor mass.
Human blood analysis
Human samples were obtained according to German federal guidelines, local ethics committee regulations (Albert-Ludwigs-University, Freiburg, Germany, HBUF 474/14 and 243/18) and the Declaration of Helsinki (1975) . 8/9 blood samples were obtained from male individuals, between 46 and 72 years old. 1/9 blood sample was obtained from a female individual, 56 years old. Blood samples from patients chronically infected with HCV were processed to isolated PBMCs that were then stored at À80 C until analysis. PBMCs were treated overnight with 5 mM sodium acetate or PBS, in medium containing FBS. Cells were then restimulated with PMA/Ionomycin and brefeldin A for 4 hours before processing them for surface and intracellular staining.
Cell culture OVA peptide-specific T cells were isolated from spleens and peripheral lymph nodes of OT-I transgenic mice (older than 8 weeks old, sex-and age-matched) and activated with the ovalbumin peptide SIINFEKL (OVA 257-264 , 100 ng/ml, New England Peptide). T cells were cultured in RPMI 1640, added with 10% heat-inactivated fetal bovine serum (GIBCO, lot n. 1640960), glutamine (4 mM), penicillin/streptomycin (1%), b-mercaptoethanol (55 mM) and glucose (concentrations indicated in the text). Cells were grown at 37 C, in 5% CO 2 , atmospheric O 2, in a humidified incubator. Briefly, cells were activated on day 0 with OVA 257-264 , with rhIL-2 (100 U/ml, Peprotech) in medium containing 25 mM glucose. After 3 days, cells were either kept in 25 mM glucose or switched to 1 mM glucose for 1 or 5 days. 1 day before analysis, cells maintained in 1 mM glucose were treated with or without 5 mM sodium acetate (Sigma) or valproic acid (1 mM, Sigma). Starting from day 2, and every day, cultured cells were harvested, washed, counted and plated at a concentration of 10 6 cells/ml in fresh medium with rhIL-2. B16 melanoma tumor cells (kindly provided by Dr. Marco Colonna) and EL4-OVA lymphoma tumor cells (E.G7-OVA [derivative of EL4]; ATCC, CRL-2113) were cultured in the medium described above, with addition of 10 mM glucose, and in the culture conditions previously described. Additional information regarding the sex of the cell lines could not be found on the ATCC website.
METHOD DETAILS
Tumor processing Solid tumors ( Figures 4A-4E and 5G-5N) were excised from mice at the indicated time post-implant and kept at +4 C. Isolated tumors were finely chopped and treated with type IA collagenase (Sigma, 1 mg/ml) and DNase I (Sigma, 50 mg/ml) in Hanks' Balanced Salt Solution (HBSS, Hyclone) for 1 hour at 37 C. After digestion, cells were washed and filtered through a 70 mm strainer to obtain single cell suspensions.
Retroviral transduction OT-I CD8
+ T cells were activated with OVA 257-264 and rhIL-2 (100 U/ml) for 27 hours in the previously described medium added with 10 mM glucose. Cells were then transduced with viruses expressing short hairpin RNA (hp) against luciferase (Ctrl Hp -GFP-), Acss2 (Acss2 Hp -GFP-), Acss1 (Acss1 Hp -hCD8-) or with the expression constructs (Ctrl OE or Acss2 OE -both expressing GFP-). Transduction was performed in the previously described medium added with polybrene (Sigma, 8 mg/ml), HEPES (Hyclone, 10 mM), glutamine (4 mM) and rhIL-2 (100 U/ml). Cells were centrifuged at 2500 rpm, for 90 minutes at 30 C, followed by 3 hours resting in the same medium. Transduced cells were then used for further analysis.
Flow cytometry
The following antibodies were used to perform surface and intracellular staining: anti-CD8a (53-6.7, Biolegend); anti-CD44 (IM7, Biolegend); anti-CD45.1 (A20, Biolegend); anti-CD45.2 (104, Biolegend); anti-PD-1 (J43, Invitrogen); anti-CD25 (3C7, Biolegend); anti-CD69 (H1.2F3, Biolegend); anti-CD62L (MEL-14, Biolegend); anti-CD71 (RI7217, Biolegend); anti-Granzyme B (NGZB, eBioscience); anti-IFNg (XMG1.2, Biolegend); anti-GFP (FM264G, Biolegend). Live cell were identified using the LIVE/DEAD fixable dead cell stain from Invitrogen.
Surface staining was performed in PBS containing 2% FBS and EDTA (2 mM), on ice for 30 minutes. Cytokine production was analyzed by intracellular staining upon restimulation with phorbol 12-myristate 13-acetate (PMA, Sigma, 50 ng/ml)/ionomycin (Sigma, 500 ng/ml) in presence of brefeldin A (Biolegend, 0.1%) for 4 hours, or with SIINFEKL peptide (100 ng/ml) in presence of brefeldin A for 12 hours. After stimulation, cells underwent surface staining, followed by fixation in Cytofix/Cytoperm fixation buffer (BD Biosciences) at +4 C for 15 minutes. Cells were then thoroughly washed, antibodies against intracellular antigens were added in presence of 1X permeabilization buffer (BD Biosciences) and the suspension was incubated for 45 minutes, on ice in the dark. CellTrace Violet (CTV) reagent (Invitrogen) was used to assess cell proliferation following the manufacturer recommendations. Cell proliferation was measured based on the fraction of live cells that diluted CTV over a period of 24 hours. Samples were assessed with FACSCalibur, FACSCanto II or LSRFortessa analyzers (BD Biosciences), or sorted using FACSAria cell sorters. Acquisition data were analyzed with FlowJo software (TreeStar).
Lactate measurement
Production of lactate, as a measure of aerobic glycolysis, was quantified in the supernatant of cultured cells 24 hours after seeding 10 6 cells/mL. Quantification was performed using a Roche Cedex Bio analyzer following manufacturer recommendations.
ELISA
Quantification of secreted IFN-g was assessed by ELISA (RND Systems) following manufacturer recommendations. Supernatant was collected 4 hours after PMA/Ionomycin restimulation of 10 6 cells/mL.
Metabolomic analysis
Upon retroviral transduction, GFP + cells were sorted by flow cytometry. Cells were then cultured in the above described medium containing 10 mM glucose, in presence of 5 mM of uniformly-labeled 13 C acetate, for 24 hours. Cells were washed with 0.9% NaCl and kept on ice. Intracellular metabolite extraction was performed with 70% ethanol, previously warmed up to 70 C. Samples were centrifuged, and the supernatants collected and dried under vacuum. Dried pellets were further processed and analyzed using gas chromatography-mass spectrometry (Agilent).
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